Glenmark’s $1.9 Billion Licensing Deal with AbbVie Turns Balance Sheet Net Cash Positive

Unknown Apr 02, 2026 800 Views

Glenmark Pharmaceuticals has achieved a major financial milestone following its landmark licensing agreement with USbased AbbVie, which is set to transform its capital structure and innovation trajectory. Key Highlights: Glenmark’s innovation arm, Ichnos Glenmark Inno...